Don’t miss out – Get your tickets early!

Join our upcoming FREE Webinar with Heather A. Lee (USA).

Topic: Aging, Saging, and Stepping into the Great Beyond: How Psychedelics Can Help Us Age, Sage, & Bring a Soulfulness to the Closing Chapters of Life

Explore the powerful potential of psilocybin and other psychedelic medicines in supporting graceful aging, neuroprotective brain health, and soulful preparation for the end of life. This webinar will dive into how these ancient medicines are not only helping maintain cognitive function as we age but also offering profound spiritual insights that ease the fear of death and enrich our final chapters. Join us to learn how psychedelics can help us step into our roles as wise elders, connected to deeper inner wisdom, and transform our approach to aging and end-of-life care.

EVENT DETAILS

DATE: 14th May 2025
TIME: 11:55pm (AEST) for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTERS

Heather A. Lee
Psychotherapist

Heather Lee has expertise at the intersection of transformational travel, psychedelic wellness, and integrative mental health. As one of the nation's first Certified Psychedelic-Assisted Psychotherapists, her work with women and psilocybin was spotlighted in Lisa Ling's CBS special on the Psychedelic Renaissance. Heather has background in Mind/Body Medicine from the Harvard Mind/Body Medical Institute and served as the Director of Women’s Health Education at the University of Virginia Medical Center. She designs and delivers psilocybin retreats in Colorado and Portugal specializing in midlife, cancer, and end-of-life care. Heather consulting expertise has been sought by high-end clients like Four Seasons Hualalai, Golden Door Spa, and One & Only Maldives, guiding industries in safely integrating mystical mindfulness and psychedelic wellness experiences into their offerings.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.

Accessibility

General information